Cardiff Oncology (CRDF) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about CRDF filings

Are insiders buying or selling Cardiff Oncology Inc (CRDF) stock?

Neither. Cardiff Oncology Inc (CRDF) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CRDF recently?

None. No member of Congress disclosed a CRDF trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CRDF smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on CRDF

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $1.1M
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about CRDF filings

Are insiders buying or selling Cardiff Oncology Inc (CRDF) stock?

Neither. Cardiff Oncology Inc (CRDF) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CRDF recently?

None. No member of Congress disclosed a CRDF trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CRDF smart-money data?

Insiders

What insiders are doing

4 trades · 6 mo

Bought$1.1M

Buys (3)

PG
Pace Gary W
Dir · Cluster · Jul 16
$1000K
bought
Signals like this: n=2459, 52% finished lower at D15, median -0.4% vs SPY +0.2%
MM
Mohindru Mani
Chief Executive Officer · Cluster · Jul 16
$50K
bought
PG
Pace Gary W
Dir · Cluster · Jun 22
$37K
bought

1 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Earnings came in 14.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.12+14.29% beat

-$0.14 expected

Revenue

$171.0K

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	-$0.12est. -$0.14	+14.29%beat	$171.0KSEC filing	+42.5%from $120.0K
Jun 30, 2026Reported Aug 11, 2026	-$0.14est. -$0.17	+17.65%beat	$104.0KSEC filing	-14.0%from $121.0K
Mar 31, 2026Reported May 14, 2026	-$0.18est. -$0.12	-50.00%miss	$41.0KSEC filing	-62.4%from $109.0K
Dec 31, 2025Reported Feb 24, 2026	-$0.11est. -$0.20	+45.00%beat	$593.0K · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$0.17est. -$0.21	+19.05%beat	$120.0KSEC filing	-27.3%from $165.0K
Jun 30, 2025Reported Jul 29, 2025	-$0.21est. -$0.20	-5.00%miss	$121.0KSEC filing	-25.8%from $163.0K
Mar 31, 2025Reported May 8, 2025	-$0.20est. -$0.19	-5.26%miss	$109.0KSEC filing	-46.8%from $205.0K
Dec 31, 2024Reported Feb 27, 2025	-$0.21est. -$0.25	+15.15%beat	$683.0K · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $0.78
High: $0.81
Low: $0.75
Prev close: $0.79
52-wk high: $3.31
52-wk low: $0.71
Mkt cap: $56.6M
ROE: -94.1%
Beta: 1.56
P/S: 111.4x
P/B: 2.2x
Profit margin: +0.0%
Op margin: -8320.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $57M

Valuation

P/S111.42
P/B2.24

Quality

Operating margin-8320.0%
ROE-94.1%
ROA-46.7%

Growth

Beta1.56

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

34balanced

20D volatility

87%annualized

52-week range

$0.77

$0.71$3.31

20D support

$0.75recent floor

20D resistance

$1.00recent ceiling

Returns

5D -11.9%20D -21.4%60D -13.6%

Price vs moving averages

SMA20 -11.7%SMA50 -27.4%SMA200 -43.7%

Volume pace

0.76xvs prior 20D

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about CRDF filings

Are insiders buying or selling Cardiff Oncology Inc (CRDF) stock?

Neither. Cardiff Oncology Inc (CRDF) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CRDF recently?

None. No member of Congress disclosed a CRDF trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CRDF smart-money data?

Smart money on CRDF

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $1.1M
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about CRDF filings

Are insiders buying or selling Cardiff Oncology Inc (CRDF) stock?

Neither. Cardiff Oncology Inc (CRDF) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded CRDF recently?

None. No member of Congress disclosed a CRDF trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this CRDF smart-money data?

Insiders

What insiders are doing

4 trades · 6 mo

Bought$1.1M

Buys (3)

PG
Pace Gary W
Dir · Cluster · Jul 16
$1000K
bought
Signals like this: n=2459, 52% finished lower at D15, median -0.4% vs SPY +0.2%
MM
Mohindru Mani
Chief Executive Officer · Cluster · Jul 16
$50K
bought
PG
Pace Gary W
Dir · Cluster · Jun 22
$37K
bought

1 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Earnings came in 14.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.12+14.29% beat

-$0.14 expected

Revenue

$171.0K

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	-$0.12est. -$0.14	+14.29%beat	$171.0KSEC filing	+42.5%from $120.0K
Jun 30, 2026Reported Aug 11, 2026	-$0.14est. -$0.17	+17.65%beat	$104.0KSEC filing	-14.0%from $121.0K
Mar 31, 2026Reported May 14, 2026	-$0.18est. -$0.12	-50.00%miss	$41.0KSEC filing	-62.4%from $109.0K
Dec 31, 2025Reported Feb 24, 2026	-$0.11est. -$0.20	+45.00%beat	$593.0K · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$0.17est. -$0.21	+19.05%beat	$120.0KSEC filing	-27.3%from $165.0K
Jun 30, 2025Reported Jul 29, 2025	-$0.21est. -$0.20	-5.00%miss	$121.0KSEC filing	-25.8%from $163.0K
Mar 31, 2025Reported May 8, 2025	-$0.20est. -$0.19	-5.26%miss	$109.0KSEC filing	-46.8%from $205.0K
Dec 31, 2024Reported Feb 27, 2025	-$0.21est. -$0.25	+15.15%beat	$683.0K · FYSEC filing	No year-ago quarter

Open: $0.78
High: $0.81
Low: $0.75
Prev close: $0.79
52-wk high: $3.31
52-wk low: $0.71
Mkt cap: $56.6M
ROE: -94.1%
Beta: 1.56
P/S: 111.4x
P/B: 2.2x
Profit margin: +0.0%
Op margin: -8320.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $57M

Valuation

P/S111.42
P/B2.24

Quality

Operating margin-8320.0%
ROE-94.1%
ROA-46.7%

Growth

Beta1.56

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

34balanced

20D volatility

87%annualized

52-week range

$0.77

$0.71$3.31

20D support

$0.75recent floor

20D resistance

$1.00recent ceiling

Returns

5D -11.9%20D -21.4%60D -13.6%

Price vs moving averages

SMA20 -11.7%SMA50 -27.4%SMA200 -43.7%

Volume pace

0.76xvs prior 20D

Cardiff Oncology Inc

Smart money at a glance

What do analysts expect?

Questions about CRDF filings

Smart money on CRDF

Questions about CRDF filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 14.3% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Cardiff Oncology Inc

Smart money at a glance

What do analysts expect?

Questions about CRDF filings

Smart money on CRDF

Questions about CRDF filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 14.3% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Cardiff Oncology Inc

Overview

Questions about CRDF filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Cardiff Oncology Inc

Overview

Questions about CRDF filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.